<DOC>
	<DOCNO>NCT02129660</DOCNO>
	<brief_summary>The purpose study assess safety 2 dos DRM04B compare 2 dos DRM04 vehicle ( 5 treatment arm ) treatment axillary hyperhidrosis apply daily 4 week follow 2-week post-dose period .</brief_summary>
	<brief_title>Comparator Study Effect DRM04B DRM 04 Subjects With Axillary Hyperhidrosis</brief_title>
	<detailed_description>This randomize , double-blind , vehicle control , parallel group , comparator study design assess safety , efficacy pharmacokinetics two dos DRM04B compare two dos DRM04 compare vehicle , 5 treatment arm . Efficacy assess gravimetric assessment sweat production use Patient Reported Outcome Hyperhidrosis Disease Severity Score ( HDSS ) . Safety assess adverse event , local skin response , serum chemistry hematology laboratory testing , ECGs , physical examination vital sign . PK blood sample take study subject .</detailed_description>
	<mesh_term>Hyperhidrosis</mesh_term>
	<criteria>Male female , 18 year age old . Primary , axillary hyperhidrosis least 6 month duration . Hyperhidrosis Disease Severity Score ( HDSS ) 3 4 baseline . For axilla , baseline gravimetric measurement sweat production least 50 mg 5 minute , rest , room temperature . Male nonpregnant , nonlactating female . Current pregnancy lactation . Prior surgical procedure hyperhidrosis . Any prior axillary treatment antihyperhidrosis medical device Any prior treatment investigational drug within 4 week prior Baseline/Day 1 within 5 elimination half live active agent , whichever longer 6 week elimination half life know . Experimental device exclude without approval Medical Monitor . Prior treatment botulinum toxin ( e.g. , Botox® ) axillary hyperhidrosis within 1 year Baseline/Day 1 . Subjects clinically significant abnormality laboratory value . Subjects positive Hepatitis HIV.Hepatitis B surface antibody positive allow subject history receive Hepatitis B vaccination clinically significant abnormality screen liver function test . Treatment cholinergic , serotonergic antagonist , dopamine partial agonist think relieve antidepressantinduced hyperhidrosis , within one month prior Baseline/Day 1 . Treatment psychotherapeutic medication less 4 month prior Baseline/Day 1 . Treatment topical systemic anticholinergic , adrenergic agonist ( clonidine ) , betablockers within 4 week baseline visit Prior treatment axillary iontophoresis within 4 week Baseline/Day 1 . Any previous IV oral treatment study drug . Prior treatment topical study drug previous trial . Axillary use nonprescription prescription antiperspirant within 2 week study enrollment . Presence condition , within 10 year enrollment , may cause secondary hyperhidrosis Menopausal woman symptom menopause sweat flush within 3 year study may enrol . Known history Sjögren 's syndrome Sicca syndrome . History glaucoma , inflammatory bowel disease , toxic megacolon , febrile illness . Men history urinary retention require catheterization due prostatic hypertrophy severe obstructive symptom prostatic hypertrophy . Abnormal finding screen ECG deem clinically significant Investigator . History presence ventricular arrhythmia , atrial fibrillation , atrial flutter . History supraventricular tachycardia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>